KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TAK) Assets Average (2018 - 2025)

Historic Assets Average for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to $99.2 billion.

  • Takeda Pharmaceutical's Assets Average rose 63.39% to $99.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $99.2 billion, marking a year-over-year increase of 63.39%. This contributed to the annual value of $99.2 billion for FY2025, which is 470.02% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Assets Average of $99.2 billion as of Q4 2025, which was up 63.39% from $97.5 billion recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Assets Average ranged from a high of $119.8 billion in Q1 2021 and a low of $95.1 billion during Q2 2025
  • Moreover, its 5-year median value for Assets Average was $102.0 billion (2024), whereas its average is $105.0 billion.
  • Over the last 5 years, Takeda Pharmaceutical's Assets Average had its largest YoY gain of 109.53% in 2021, and its largest YoY loss of 9990.85% in 2021.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's Assets Average stood at $112.9 billion in 2021, then dropped by 10.89% to $100.6 billion in 2022, then decreased by 1.0% to $99.6 billion in 2023, then fell by 1.07% to $98.5 billion in 2024, then rose by 0.63% to $99.2 billion in 2025.
  • Its Assets Average was $99.2 billion in Q4 2025, compared to $97.5 billion in Q3 2025 and $95.1 billion in Q2 2025.